Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease

@article{Danelich2015SafetyON,
  title={Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease},
  author={Ilya M Danelich and Sampaguita S Wright and Jennifer M. Lose and Brittany J Tefft and Jonathan D Cicci and Brent N. Reed},
  journal={Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year={2015},
  volume={35}
}
Nonsteroidal antiinflammatory drugs (NSAIDs) are used in the management of a variety of conditions, but their prevalence is likely underreported as a result of widespread availability and the perception that nonprescription therapies are unnecessary to report during medication history taking. However, NSAIDs are associated with a number of adverse effects, especially in patients with cardiovascular disease (CVD). Patients with CVD and comorbidities for which NSAIDs may provide symptomatic… 
Review: The choice and cardiovascular safety of particular nonsteroidal anti-inflammatory drugs
TLDR
It was observed that despite existing guidelines no single NSAID could be considered to be the safest one due to a lack of superiority trials and common adverse effects of NSAIDs.
Aspectos de seguridad en el tratamiento del dolor con analgésicos antiinflamatorios no esteroideos
TLDR
The objective of this work is to review the safety aspects of the treatment with NSAIDs in chronic analgesic management, with specific monitoring of gastrointestinal, cardiovascular, renal hepatic and hematologic complications.
[The use of nonsteroidal anti - inflammatory drugs in polymorbid pathology].
TLDR
The literature review presents the possibilities of using non - steroidal anti - inflammatory drugs (NSAIDs) for polymorbid pathology and risk factors for the development of undesirable effects on the cardiovascular, digestive, urinary and other systems are considered.
Use of Over-the-Counter Products in Lebanese Adults with Cardiovascular Disease
TLDR
The use of OTC products was highly prevalent among patients with CVD with potential interactions with prescription medications and patient diseases, and clinicians are strongly encouraged to inquire about OTC product use and counsel patients about the risks and benefits associated with such products.
Naproxen in Pain and Inflammation – A Review
TLDR
It has been established that the duration of pain relief after a single dose of naproxen is significantly greater than after the intake of ibuprofen-containing products of equal concentration in the post-operative period of dental intervention.
Potential Cardiovascular Drug Interactions in Egypt: Incidence, Outcomes, Mechanism, and Management
TLDR
Preventive programs are required for the increased incidence of potential cardiovascular drug interaction in Egypt and drug monitoring, minimizing risk factors, and increasing awareness of potentialdrug interaction in cardiovascular diseases are recommended in clinical practice in Egypt.
Cyclo‐oxygenase selectivity and chemical groups of nonsteroidal anti‐inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase
TLDR
The reporting frequency of HSRs for NSAIDs based on their relative inhibitory potency toward COX enzymes and chemical groups, including the presence/absence of a functional sulfonamide group, in strata observed 5 years after market authorization is assessed.
Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis
TLDR
It is emphasized that adequate control of disease activity and the risk factors are needed for managing RA-related comorbidities, and may provide useful recommendations for rheumatologists on managing RA.
...
...

References

SHOWING 1-10 OF 64 REFERENCES
Gastrointestinal Safety of Nonsteroidal Antiinflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors in Patients on Warfarin
TLDR
In situations where patients require NSAIDs and cannot be managed using other therapies, the results suggest that selective COX-2 inhibitors are associated with fewer hospitalizations for GI bleeding.
Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.
TLDR
NSAIDs are frequently used in patients with HF and are associated with increased risk of death and cardiovascular morbidity, inasmuch as even commonly used NSAIDs exerted increased risk.
Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.
TLDR
The burden of illness resulting from NSAID-related CHF may exceed that resulting from gastrointestinal tract damage and was increased to a greater extent with long half- life than with short half-life drugs.
A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure.
TLDR
In short-term use, NSAIDs vary considerably in their effect on blood pressure, and indomethacin and naproxen were associated with the largest increases in blood pressure.
Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.
TLDR
In the general population, it is found that a greater risk of stroke is found with current use of nonselective and COX-2-selective NSAIDs.
Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis
TLDR
A stable estimate of the overall effect of various NSAIDs on blood pressure is produced to evaluate possible mechanisms by which NSAID therapy may alter blood pressure and to determine potential predisposing factors for this interaction.
Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population.
TLDR
People on antihypertensive therapy taking NSAIDs had systolic blood pressures approximately 5 mmHg higher than those not takingNSAIDs, and were more likely to have syStolic blood pressure above 140mmHg (odds ratio = 2.19, 95% confidence interval 1.33, 3.61).
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.
TLDR
Use of NSAIDs in elderly patients taking diuretics is associated with a 2-fold increased risk of hospitalization for CHF, especially in those with existing serious CHF.
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs.
TLDR
It is suggested that regular use of nonsteroidal antiinflammatory drugs (NSAIDs) inhibits the clinical benefit of aspirin in the primary prevention of myocardial infarction, and concomitant administration of NSAIDs antagonizes the irreversible platelet inhibition induced by aspirin.
Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study.
TLDR
In patients with prevalent heart failure, current use of NSAIDs is associated with a substantially increased risk of a relapse, and the use ofNSAIDs is not associated with an increasedrisk of incident heart failure.
...
...